glucose-dependent insulinotropic polypeptide news

All news on glucose-dependent insulinotropic polypeptide (also known as Gastric inhibitory polypeptide and GIP): plants, production capacities, investments and involved companies.

23 July 2026

Lilly's retatrutide shows large weight and A1C reductions in Phase 3 TRIUMPH‑2 and TRIUMPH‑3

First‑in‑class triple agonist delivered large 80‑week weight losses and meaningful A1C and cardiometabolic improvements in difficult‑to‑treat obesity populations.

Who will be producing glucose-dependent insulinotropic polypeptide in the future?

Find out with chemXplore Alpha

Learn more